We are excited to announce a partnership between Nexomic and Genomics England.
This partnership will enable us to validate DeepOmic, our tumour-agnostic foundation model, using large-scale multi-omics data from cancer patients.


About Nexomic
Nexomic is a Dublin-based precision oncology TechBio company using frontier AI and patient multi-omic data to understand the biology behind treatment response and resistance. At its core is DeepOmic, a tumour-agnostic multi-omic AI foundation model trained on patient data from more than 30 countries. Built on this foundation, Nexomic develops solutions across the oncology lifecycle, including DISCOVER for therapeutic discovery and DECODE for de-risking oncology drug development and clinical trials.


About Genomics England

A UK national genomics data platform that sequences human genomes to deliver precise medical insights, accelerate clinical research, and transform patient care for rare diseases and cancers.